Key result
Lipoprotein(a) is linked to coronary heart disease, but causality remains unproven.
There is a clear association between Lipoprotein(a) and coronary heart disease, though the extent of causality remains to be determined.
Lp(a) may refine CHD risk stratification; leaves open causality and need for targeted outcome trials.
These prospective studies demonstrate a clear association between Lp(a) and CHD, but further studies are needed to determine the extent to which this is causal.
No takes yet. Share an insight, caveat, or question.
Danesh et al. (2000) studied this question. Lipoprotein(a) is clearly associated with coronary heart disease, though further studies are needed to determine causality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: